Home > Healthcare > Medical Devices > Diagnostic Devices > Disposable Endoscopes Market

Disposable Endoscopes Market Trends

Report ID: GMI6082
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Disposable Endoscopes Market Trends

There has been an increase in the prevalence of several chronic diseases including the gastro-intestinal disorders and cancers owing to the lifestyle changes observed over the years. Gastrointestinal diseases affect the gastrointestinal (GI) tract from the mouth to the rectum. Gastrointestinal disorders encapsulate a wide range of disorders including non-alcoholic fatty liver disease gastroesophageal reflux disease, and colorectal cancer. A rise in the number of patients with colorectal cancer has been recorded in several countries globally. For instance, according to the European Commission and ENCR data, in 2021, around colorectal cancer accounted for 12.7% of all new cancer diagnoses and 12.4% of mortality due to cancer in the European region.

Additionally, gastrointestinal cancer yields 35% of cancer related deaths and 26% percent of the global cancer prevalence. With the rise in the number of the cancer instances, the adoption of disposable endoscopes as means to diagnose or assist in treatment subsequently rises.

Instances of gastric cancers and lung cancer are higher in older population. With rise in geriatric population and rising healthcare expenditure in developing countries, the endoscopic procedures are anticipated to spur in folds over the analysis timeframe. Governments and healthcare organizations have been implementing screening and early detection programs for various diseases, including gastrointestinal cancers and lung diseases. Disposable endoscopes are widely used in screening procedures, such as colonoscopies and bronchoscopies, enabling early detection and intervention.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Disposable endoscopes industry size was worth more than USD 2.3 billion in 2023 and is estimated to reach around USD 9.7 billion by 2032, driven by the rising prevalence of gastrointestinal disorders, cancer, and other chronic conditions.

The bronchoscopy application segment held over 30% of the market in 2022 and is projected to grow at robust CAGR owing to the rising prevalence of tumours and lung cancer worldwide.

North America disposable endoscopes industry share was valued at USD 846.1 million in 2022 and is projected to expand through 2032 attributed to the presence of leading market players, and the growing number of patients suffering from GI disorders.

Major firms engaged in the disposable endoscopes industry include Ambu A/S, Boston Scientific Corporation, BPL Medical Technologies, CooperSurgical, Inc., Flexicare Medical Ltd., HOYA Corporation, KARL STORZ, OBP Medical Corporation, and Olympus Corporation.